InvestorsHub Logo
icon url

Here Today

04/10/18 9:07 PM

#223843 RE: georgejjl #223842

Great find and as always and Thank you for always providing your DD and opinions. It means a lot to some of us here on the board.
icon url

KMBJN

04/10/18 11:21 PM

#223847 RE: georgejjl #223842

So you are telling us your guess was only off by 40% absolute difference in SOM incidence ... or overestimated the benefit of brilacidin by over 3 times.

Top line mITT 60% placebo vs. 43% brilacidin developed SOM. 17% absolute difference versus your guess of 56% (70% and 14%).

Consistently overoptimistic at least.

I tend to be optimistic myself so see where you are coming from somewhat.

Hope a BP likes the modest benefit in preventing SOM with a safe, relatively patient friendly rinse and willing to partner on Phase 3 studies.




icon url

brainlessgoat

04/10/18 11:52 PM

#223848 RE: georgejjl #223842

George jj I… very nice call, right on!!!
icon url

frrol

04/11/18 8:28 AM

#223860 RE: georgejjl #223842

That's not the B-OM results. But it is another example of the foolish mistakes in stats and "predictions". Biotech is very tricky for retail investors.